u nice Stocks shook off a choppy start to finish higher Monday, as Wall Street kicked off a holiday-shortened week. The S&P 500 ended 0.7% higher after having been down 0.5% in the early going. The Dow Jones Industrial Average also recovered from an early slide to eke out a 0.2% gain. The tech-heavy Nasdaq composite rose 1%. Gains in technology and communications stocks accounted for much of the gains, outweighing losses in consumer goods companies and elsewhere in the market. Semiconductor giant Nvidia, whose enormous valuation gives it an outsize influence on indexes, rose 3.7%. Broadcom climbed 5.5% to also help support the broader market. Walmart fell 2% and PepsiCo slid 1%. Japanese automakers Honda and Nissan said they are talking about combining in a deal that might also include Mitsubishi Motors. U.S.-listed shares in Honda jumped 12.7%, while Nissan ended flat. Eli Lilly rose 3.7% after announcing that regulators approved Zepbound as the first and only prescription medicine for adults with sleep apnea. Department store Nordstrom fell 1.5% after it agreed to be taken private by Nordstrom family members and a Mexican retail group in a $6.25 billion deal. All told, the S&P 500 rose 43.22 points to 5,974.07. The Dow gained 66.69 points to 42,906.95. The Nasdaq rose 192.29 points to 19,764.89. Traders got a look at a new snapshot of U.S. consumer confidence Monday. The Conference Board said that consumer confidence slipped in December. Its consumer confidence index fell back to 104.7 from 112.8 in November. Wall Street was expecting a reading of 113.8. The unexpectedly weak consumer confidence update follows several generally strong economic reports last week. One report showed the overall economy grew at a 3.1% annualized rate during the summer, faster than earlier thought. The latest report on unemployment benefit applications showed that the job market remains solid. A report on Friday said a measure of inflation the Federal Reserve likes to use was slightly lower last month than economists expected. Worries about inflation edging higher again had been weighing on Wall Street and the Fed. The central bank just delivered its third cut to interest rates this year, but inflation has been hovering stubbornly above its target of 2%. It has signaled that it could deliver fewer cuts to interest rates next year than it earlier anticipated because of concerns over inflation. Expectations for more interest rate cuts have helped drive a roughly 25% gain for the S&P 500 in 2024. That drive included 57 all-time highs this year. Inflation concerns have added to uncertainties heading into 2025, which include the labor market's path ahead and shifting economic policies under an incoming President Donald Trump. "Put simply, much of the strong market performance prior to last week was driven by expectations that a best-case scenario was the base case for 2025," said Brent Schutte, chief investment officer at Northwestern Mutual Wealth Management Company Treasury yields rose in the bond market. The yield on the 10-year Treasury rose to 4.59% from 4.53% late Friday. European markets closed mostly lower, while markets in Asia gained ground. Wall Street has several other economic reports to look forward to this week. On Tuesday, the U.S. will release its November report for sales of newly constructed homes. A weekly update on unemployment benefits is expected on Thursday. Markets in the U.S. will close at 1 p.m. Eastern on Tuesday for Christmas Eve and will remain closed on Wednesday for Christmas.

Rush Enterprises, Inc. Adopts $150 Million Stock Repurchase ProgramAs he reflects on the strange turn of events that led to the arrival of Dee Dee, John can't help but appreciate the humor and unpredictability of life. What started as a simple online purchase gone awry turned into a heartwarming tale of unexpected friendship and joy.

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

NEW YORK--(BUSINESS WIRE)--Nov 21, 2024-- Perfect Corp. (NYSE: PERF), a global leader in augmented reality (AR) and artificial intelligence (AI) technology for beauty and fashion, recently partnered with Japan’s well-known Tohoku Rakuten Golden Eagles baseball team, bringing a touch of nostalgia to the stadium with AI-powered retro-style player images. This partnership, unveiled during the Rakuten Eagles’ recent games, allowed fans to experience the fun of AI-driven photo editing through Perfect Corp.’s popular YouCam Perfect app. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121998152/en/ Perfect Corp. Teams Up with the Tohoku Rakuten Golden Eagles Baseball Team to Bring AI-Generated Retro Baseball Player Photos to Fans (Photo: Business Wire) As baseball fans around the world gather for this season’s biggest international baseball tournament, Perfect Corp. is tapping into the excitement by connecting fans with groundbreaking AI technology. The Rakuten Eagles partnership is a prime example, showcasing YouCam Perfect’s advanced AI photo-editing engine, which transformed images of the Rakuten Eagles players into vintage, retro-styled portraits inspired by Japan’s Showa and Heisei eras. Displayed on stadium screens, these AI-enhanced images retained the players' unique features while adding nostalgic backdrops and outfits, creating an unforgettable atmosphere for spectators. “We’re thrilled to offer fans an innovative way to celebrate the players they admire through the power of AI,” said Alice Chang, Founder and CEO of Perfect Corp. “By using our AI Studio feature to transform photos into nostalgic artwork, we hope to add a bit of magic to the fan experience, combining timeless styles with the latest technology.” Get Game-Ready with YouCam Perfect’s Generative AI Effects As baseball fever spreads worldwide during this season’s premier games, fans of the Rakuten Eagles, along with baseball enthusiasts everywhere, can get in on the fun by downloading the YouCam Perfect app and exploring its retro filters and other GenAI-powered special effects. Through the AI Studio feature, users can choose from a variety of themes that allow them to personalize their photos with a similar nostalgic touch or other imaginative vibes. The YouCam Perfect app currently offers over 110 unique styles for users to explore, making it easy to create and share custom photos with friends and family. Fans are invited to celebrate baseball season in style with this accessible, fun technology. Download the YouCam Perfect app here: https://www.perfectcorp.com/consumer/apps/ycp Learn more about Perfect Corp.'s solutions here: https://www.perfectcorp.com/consumer About Perfect Corp. Perfect Corp. (NYSE: PERF) leverages ‘Beautiful AI’ innovations to make our world more beautiful. As a pioneer and leader in the space, Perfect Corp. works with over 650 partners around the globe to empower brands to embrace the digital-first world by transforming shopping journeys through digital tech innovations. Perfect Corp.’s suite of enterprise solutions delivers synergistic, technology-driven experiences that facilitate sustainable, ultra-personalized, and engaging shopping journeys through hyper-realistic virtual try-ons, AI-powered skin analyses, personalized product recommendation tools and many more Beautiful AI innovations. View source version on businesswire.com : https://www.businesswire.com/news/home/20241121998152/en/ CONTACT: Press Contacts Perfect Corp. officialwebsite: https://www.perfectcorp.com Perfect Corp. onLinkedIn: https://www.linkedin.com/company/perfect-corp/ Perfect Corp. officialBlog: https://www.perfectcorp.com/business/blog/1 Corporate: Tony Tsai atpress@perfectcorp.comor by phone: +886-2-8667-1265, ext. 2167 USA: Allie Murphy atcontact_pr@perfectcorp.comor by phone +1 (415) 625-8555 Japan: Ryoko Nakagawa atcontact_pr_jpn@perfectcorp.comor by phone: +81-3-5875-6651 China: Winter Zhang atWinter_zhang@perfectcorp.comor by phone: +86-166-2139-1855 Europe: Aurélie Léveillé atcontact_pr_fr@perfectcorp.com UAE: Marwa Mohamed atcontact_pr_uae@perfectcorp.comor by phone: +971 (0) 50-728-4178 India: Ananya Tandon atcontact_pr_in@perfectcorp.com Indonesia: Efon Dea atcontact_pr_id@perfectcorp.com KEYWORD: NEW YORK UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC INDUSTRY KEYWORD: SPORTS TECHNOLOGY FASHION COSMETICS APPS/APPLICATIONS RETAIL SOFTWARE ARTIFICIAL INTELLIGENCE AUDIO/VIDEO MOBILE/WIRELESS BASEBALL SOURCE: Perfect Corp. Copyright Business Wire 2024. PUB: 11/21/2024 04:30 PM/DISC: 11/21/2024 04:28 PM http://www.businesswire.com/news/home/20241121998152/en

Another common misconception is the assumption that "Trump 2.0" represents a linear progression of ideas and policies from the Trump era. According to Professor Ouyang Hui, this oversimplification fails to account for the dynamic nature of politics. Instead of viewing "Trump 2.0" as a straightforward continuation, it is essential to consider the potential diversification and evolution of political ideologies in response to changing societal dynamics.

Frontline, Golden Ocean, Hafnia set to report earnings Wednesday

The intersection of innovation and development in the commercial real estate sector has always been a dynamic and evolving landscape. Recently, in a groundbreaking event, Zhou Haichao, a prominent figure in the real estate industry, was invited to the Creative Course Classroom as a guest speaker to share insights on the future of commercial real estate. The event was hosted by Zhao Xiuchi, an esteemed expert in the field, who led a thought-provoking discussion on the latest trends and challenges facing the industry.Electoral Commission Faces Backlash as Nana Yaa Jantuah Drops Bold Message About 2024 Polls

Manmohan Singh, India’s economist-turned-Prime Minister, was known for his grace, soft-spoken demeanor, and sharp economic vision. Throughout his career, he earned praise from both rivals and colleagues. The architect of India’s economic reforms, Singh passed away in Delhi on Thursday night at the age of 92. His legacy as a transformative leader and a guiding force in India’s economic journey will be remembered fondly. Singh’s death was announced by the All India Institute of Medical Sciences(AIIMS) in Delhi, where he was admitted to the Emergency ward around 8:30 PM in critical condition. Earlier this year, Prime Minister Modi praised former PM Manmohan Singh as an “inspiration” for lawmakers during a heartfelt farewell event for retiring members. Singh concluded his remarkable 33-year-long parliamentary career in the Rajya Sabha in April this year, leaving behind a legacy of dedication and service that continues to inspire many. His passing marks the end of an era, and his contributions to India’s economic and political landscape will be remembered fondly by many. Prime Minister Modi’s praise came after Dr. Manmohan Singh demonstrated his commitment by arriving in a wheelchair to cast his vote in the Parliament. “I remember during the voting in the House, it was known that the treasury bench would win but Dr Manmohan Singh came on his wheelchair and cast his vote. This is an example of a member being alert of his duties. He was an inspirational example,” PM Modi said, referring to the vote Manmohan Singh cast over a key legislation. #ManmohanSingh was ill, knew that his one vote can't change the outcome in NDA Majority Rajyasabha, yet he used to come for voting in a WHEELCHAIR. ~ PM Narendra Modi praised him for this stand alone dedication for Democracy 🇮🇳 Om Shanti. pic.twitter.com/kKZlR5npfh — The Analyzer (News Updates🗞️) (@Indian_Analyzer) December 26, 2024 In August 2023, despite his frail health, Dr. Singh made a determined appearance in a parliamentary debate on a bill granting the central government more control over Delhi’s administrative matters, arriving in a wheelchair. He also used a wheelchair to cast his vote during the Presidential elections. These moments highlighted his dedication and resilience, leaving a lasting impression on those who witnessed his steadfast devotion to his duties. In 2022, Union Minister Nitin Gadkari expressed his deep respect for Manmohan Singh, stating that the nation would always remain indebted to the former Prime Minister. Gadkari reminisced about his time as a minister in Maharashtra during the mid-1990s, recalling how Singh’s economic reforms enabled him to secure funds for building roads in the state. This acknowledgment highlighted the lasting impact of Singh’s visionary policies on India’s infrastructure development. His contributions continue to be felt and appreciated, underscoring the profound influence he had on the country’s progress. Also Read: Former PM Manmohan Singh Passes Away: When ‘Maunmohan’ Took A Jab At Narendra Modi Against ‘Silent PM’ Written By Lakshmi Ranjith( MENAFN - EIN Presswire) Clean Remedies carries an extensive line of CBD and THC products, including tinctures, gummies, and drink mixes. Clean Remedies launched their 10mg Delta 9 THC Gummies this year, which is available in a natural watermelon flavor. As 2024 comes to a close, Clean Remedies, a leader in CBD and THC wellness products, takes a moment to reflect on a year of milestones. AVON, OH, UNITED STATES, December 26, 2024 /EINPresswire / -- As 2024 comes to a close, Clean Remedies, a leader in CBD and THC wellness products, takes a moment to reflect on a year of milestones and express gratitude to its customers. Over the year, Clean Remedies has had a number of successful product launches that have helped individuals and families better their health and wellness. This year, Clean Remedies introduced several products that further solidified its reputation as a trusted name in the wellness industry. The Trippy Mushroom Collection marked a step into psychedelic wellness, bringing a new dimension to natural healing by tapping into the potential of mushrooms. The introduction of THCa Flower catered to growing interest in alternative cannabinoids, offering a fresh addition to the company's product portfolio. Additionally, their new 10mg Delta 9 THC Gummies have become a customer favorite, offering a carefully crafted, enjoyable microdosing experience for relaxation and balance. With an eye on the future, Clean Remedies is preparing to introduce a new line of functional mushroom products at the beginning of 2025. These offerings aim to make wellness even more accessible and enjoyable by combining science-backed benefits with simplicity and convenience. “Looking ahead to 2025, we're developing some exciting new products to keep wellness simple, fun, and as stress-free as possible.” Meredith Farrow, the founder and CEO of Clean Remedies, said.“Trust me, you'll want to keep an eye out!” Clean Remedies attributes its success to its customers, whose trust and business have fueled the brand's growth. The company extends its heartfelt gratitude to everyone who has supported its journey, whether through trying products (like their broad spectrum Delta 8 THC oil ), sharing feedback, or engaging with the brand's mission. Clean Remedies has collected hundreds of five-star reviews across their site over the past year.“The taste, dosage, and overall experience with the Delta 8 THC Gummies are great.” said one reviewer.“I have never tried THC products and feel like I hit the perfect one the first time. I especially appreciated the in-depth information about the product, the industry, and the company and how they operate in this space. I will be getting more when I run out.” Clean Remedies is dedicated to promoting wellness through high-quality CBD and THC products crafted with care and integrity. With a focus on natural, effective solutions, the brand strives to make wellness simple, accessible, and enjoyable for all. As 2024 ends and the new year approaches, Clean Remedies looks forward to continuing its journey with its community of wellness enthusiasts. Together, the company aims to make 2025 another year of innovation, growth, and gratitude. Meredith Farrow Clean Remedies +1 216-777-3133 email us here Visit us on social media: Facebook Instagram YouTube TikTok Our Clean Remedies Story Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN26122024003118003196ID1109033737 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.